Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-21
1998-08-04
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514518, 514618, 514679, 514709, 514710, 544391, 560 11, 560107, 560255, 562429, 564162, 568 27, 568 34, 568 36, 568 37, A61K 3110, A61K 31165, C07C 5942, C07C31714
Patent
active
057894132
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5393790 (1995-02-01), Reitz et al.
Black Cameron
Grimm Erich
Hughes Greg
Leger Serge
Prasit Petpiboon
Billups Richard C.
Merck Frosst Canada Inc.
Panzer Curtis C.
Rao Deepak
Rose David L.
LandOfFree
Alkylated styrenes as prodrugs to COX-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylated styrenes as prodrugs to COX-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylated styrenes as prodrugs to COX-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177443